Haglund’s deformity, often clinically identified by the triad of retrocalcaneal exostosis, Achilles tendinopathy, and retrocalcaneal bursitis, presents a persistent and painful challenge for distance runners and high-impact athletes. Commonly known as the “pump bump,” this bony enlargement on the posterior superior aspect of the calcaneus (heel bone) is not inherently painful. Instead, the condition becomes symptomatic when the rigid posterior heel counter of footwear repeatedly irritates the bone and compresses the adjacent, sensitive tissues, primarily the bursa and the Achilles tendon insertion. For a runner, where the foot cycles thousands of times per session, this friction translates into chronic inflammation and debilitating pain, often forcing cessation of the activity. The successful non-operative management of Haglund’s deformity in a running population is fundamentally contingent upon the strategic selection and meticulous modification of running shoes to eliminate pressure on the bony prominence while maintaining necessary stability and cushioning for high-mileage training.
The core pathophysiology dictates the primary footwear requirement. Haglund’s deformity is an osseous enlargement, and its irritation is purely mechanical, a result of a fixed external object (the shoe’s heel counter) pressing against a fixed anatomical prominence. The condition is often exacerbated in runners with a cavus foot (high arch) structure, where the calcaneal pitch is steeper, pushing the posterior superior heel further back and up into the shoe. Furthermore, a tight Achilles tendon can also contribute, causing the soft tissues to be “sandwiched” more tightly between the bone and the shoe. The ultimate goal of shoe selection, therefore, is to create a conflict-free zone around the exostosis. This is achieved by systematically evaluating three critical shoe design parameters: the rigidity of the heel counter, the height of the heel collar, and the fit of the midfoot and forefoot.
The most crucial selection criterion is the rigidity and contour of the posterior heel counter. Rigid, stiff plastic heel counters, common in stability and motion control running shoes, must be strictly avoided as they act like a vice, relentlessly squeezing the inflamed area. Runners must prioritize shoes that feature a flexible, soft, or completely unstructured heel counter. A compliance test—flexing the material—should be performed; if the material is easily compressed and offers no resistance, it is generally safer. Some shoe models specifically marketed as “minimalist” or “barefoot” shoes often meet this criterion due to their simplified structure, though these may compromise the needed cushioning. Conversely, shoes designed with a prominent, curved Achilles notch or a soft, well-padded collar may offer relief by gently accommodating the prominence rather than aggressively containing it. The objective is protection, not correction, of the heel’s anatomical structure.
The second crucial consideration is the height and depth of the shoe’s collar. Many conventional running shoes feature a high heel collar that terminates directly over the site of the bony prominence, creating peak compressive forces. A lower-profile shoe, where the heel counter dips below the exostosis, can provide immediate symptomatic relief by completely bypassing the painful area. Alternatively, seeking shoes with a deeper heel cup may allow the foot to sit lower within the shoe, thus positioning the bony prominence beneath the top edge of the collar. While depth and height are interconnected, the runner’s priority must be to ensure the top edge of the shoe does not abut the painful area.
Beyond selection, various shoe modifications are often necessary to sustain pain-free running. The most common intervention involves lacing techniques. The standard heel-lock lacing, which tightens the shoe around the ankle, must be avoided as it increases posterior pressure. The recommended modification is the skip-lace technique, where the laces are routed to bypass the eyelets directly over the area of maximum pressure on the dorsal aspect of the foot, near the bony prominence. This allows the lower part of the shoe to remain secure while preventing the top lace row from pulling the heel counter inward. A more invasive, but highly effective, modification of last resort is the “windowing” technique, where a podiatrist or orthopedic shoe technician cuts a small, vertical, inverted ‘V’ or ‘U’ shape into the plastic heel counter directly behind the exostosis. This creates a pressure-relief port, effectively eliminating contact at the point of irritation.
Finally, managing the runner’s underlying biomechanics must be integrated with the shoe modifications. Since Haglund’s often coexists with a supinated or high-arched foot, which typically has poor shock absorption, the forefoot and midfoot features remain vital. The selected shoe must offer adequate cushioning in the midsole (e.g., highly cushioned neutral shoes) to mitigate ground reaction forces transmitted up the leg, without sacrificing the essential flexible heel counter. Furthermore, a moderate heel-to-toe drop (typically 10-12 mm) is preferable for runners with coexisting Achilles tendinopathy, as it slightly reduces the strain on the Achilles complex during weight-bearing, facilitating the overall healing process.
Haglund’s deformity demands a non-compromising approach to running footwear, making the heel counter the single most important design element to scrutinize. Successful long-term management requires a synergistic strategy: selecting shoes with a soft, flexible, and low-profile heel counter, applying meticulous lacing and modification techniques to ensure zero contact with the bony prominence, and utilizing proper cushioning and drop to address the associated biomechanical deficiencies. Only when this comprehensive, shoe-focused conservative protocol fails to restore pain-free running, typically over a period of six to twelve months, should surgical options be considered to excise the exostosis.